$MFIN
MEDALLION FINANCIAL CORP

2023 Q2 Form 10-Q Financial Statement

#000095017023018931 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $61.73M $55.84M
YoY Change 31.02% 28.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.238M $1.300M
YoY Change 2.82% -20.73%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $15.04M $12.24M
YoY Change 82.69% 65.97%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $21.15M $23.26M
YoY Change 7.56% 43.69%
Income Tax $5.472M $6.382M
% Of Pretax Income 25.87% 27.44%
Net Earnings $14.17M $15.36M
YoY Change 6.54% 56.09%
Net Earnings / Revenue 22.96% 27.51%
Basic Earnings Per Share $0.63 $0.69
Diluted Earnings Per Share $0.62 $0.67
COMMON SHARES
Basic Shares Outstanding 23.32M 23.32M
Diluted Shares Outstanding 22.85M 22.98M

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $135.9M $69.31M
YoY Change 61.55% -33.38%
Cash & Equivalents $82.26M $20.78M
Short-Term Investments $53.69M $48.53M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $13.34M $13.40M
YoY Change 6.19% 15.48%
Goodwill $150.8M $150.8M
YoY Change 0.0% 0.0%
Intangibles $21.32M $21.68M
YoY Change -6.34% -6.25%
Long-Term Investments $65.10M $10.65M
YoY Change 494.92% 5.73%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.519B $2.352B
YoY Change 19.27% 19.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.11M $29.15M
YoY Change 945.97% 850.23%
Accrued Expenses $7.629M $10.38M
YoY Change -31.77% -2.98%
Deferred Revenue
YoY Change
Short-Term Debt $67.88M $38.50M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $112.6M $79.15M
YoY Change 664.61% 186.07%
LONG-TERM LIABILITIES
Long-Term Debt $178.1M $175.9M
YoY Change -18.8% -20.06%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $178.1M $175.9M
YoY Change -18.8% -20.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $112.6M $79.15M
Total Long-Term Liabilities $178.1M $175.9M
Total Liabilities $2.200B $1.977B
YoY Change 25.77% 23.18%
SHAREHOLDERS EQUITY
Retained Earnings $82.54M $70.24M
YoY Change 65.97% 82.89%
Common Stock $285.7M $284.5M
YoY Change 1.35% 1.22%
Preferred Stock
YoY Change
Treasury Stock (at cost) $45.54M $45.54M
YoY Change 28.24% 78.33%
Treasury Stock Shares $5.602M $5.602M
Shareholders Equity $319.0M $306.4M
YoY Change
Total Liabilities & Shareholders Equity $2.519B $2.352B
YoY Change 19.27% 19.58%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $14.17M $15.36M
YoY Change 6.54% 56.09%
Depreciation, Depletion And Amortization $1.238M $1.300M
YoY Change 2.82% -20.73%
Cash From Operating Activities $29.16M $29.13M
YoY Change 8.87% 18.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$183.9M -$81.44M
YoY Change 13.13% -7.12%
Cash From Investing Activities -$183.9M -$81.44M
YoY Change 13.13% -7.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 146.9M 79.10M
YoY Change 19.15% 2.27%
NET CHANGE
Cash From Operating Activities 29.16M 29.13M
Cash From Investing Activities -183.9M -81.44M
Cash From Financing Activities 146.9M 79.10M
Net Change In Cash -7.828M 26.78M
YoY Change -37.2% 87.17%
FREE CASH FLOW
Cash From Operating Activities $29.16M $29.13M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.medallion.com/20230331#PropertyEquipmentAndRightOfUseAssetNet
CY2021Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2026-02-28
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://www.medallion.com/20230331#PropertyEquipmentAndRightOfUseAssetNet
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001000209
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-768000
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
2095000
CY2023Q1 us-gaap Other Assets
OtherAssets
27625000
CY2023Q1 dei Entity File Number
EntityFileNumber
001-37747
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
MEDALLION FINANCIAL CORP
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3291176
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
437 MADISON AVENUE, 38th Floor
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
NEW YORK
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10022
CY2023Q1 dei City Area Code
CityAreaCode
212
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
328-2100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
MFIN
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
23321523
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20778000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33172000
CY2023Q1 us-gaap Federal Funds Sold
FederalFundsSold
111604000
CY2022Q4 us-gaap Federal Funds Sold
FederalFundsSold
72426000
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
48529000
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
48492000
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
10653000
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10293000
CY2023Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1984180000
CY2022Q4 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1916953000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
70280000
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
63845000
CY2023Q1 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1913900000
CY2022Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
1853108000
CY2023Q1 us-gaap Goodwill
Goodwill
150803000
CY2022Q4 us-gaap Goodwill
Goodwill
150803000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21675000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22035000
CY2023Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
20467000
CY2022Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
21819000
CY2023Q1 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
13401000
CY2022Q4 mfin Property Equipment And Right Of Use Asset Net
PropertyEquipmentAndRightOfUseAssetNet
13168000
CY2023Q1 us-gaap Interest Receivable
InterestReceivable
12235000
CY2022Q4 us-gaap Interest Receivable
InterestReceivable
12613000
CY2023Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
0
CY2022Q4 us-gaap Other Assets
OtherAssets
19855000
CY2023Q1 us-gaap Assets
Assets
2351670000
CY2022Q4 us-gaap Assets
Assets
2259879000
CY2023Q1 us-gaap Minority Interest
MinorityInterest
68788000
CY2023Q1 us-gaap Deposits
Deposits
1695300000
CY2022Q4 us-gaap Deposits
Deposits
1607110000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
175864000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
214320000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26205000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
26753000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8168000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8408000
CY2023Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
38500000
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
5000000
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4039000
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4790000
CY2023Q1 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
1113000
CY2022Q4 us-gaap Taxes Payable Current And Noncurrent
TaxesPayableCurrentAndNoncurrent
0
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
27328000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
22974000
CY2023Q1 us-gaap Liabilities
Liabilities
1976517000
CY2022Q4 us-gaap Liabilities
Liabilities
1889355000
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28912147
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28663827
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
289000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
287000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
284221000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
283663000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
5602154
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5602154
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
45538000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
45538000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2843000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3349000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
70236000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
66673000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
306365000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
301736000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
68788000
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
1707000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
375153000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
370524000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2351670000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2259879000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23309993
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
23061673
CY2023Q1 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
13.14
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
13.08
CY2023Q1 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
7200000
CY2022Q4 mfin Loan Foreclosure Collateral Sale To Third Party
LoanForeclosureCollateralSaleToThirdParty
7500000
CY2022Q4 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2200000
CY2023Q1 mfin Short Term Lease Liabilities
ShortTermLeaseLiabilities
2200000
CY2023Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
55169000
CY2022Q1 us-gaap Interest And Fee Income Loans And Leases
InterestAndFeeIncomeLoansAndLeases
43064000
CY2023Q1 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
674000
CY2022Q1 mfin Interest And Dividends On Investment Securities
InterestAndDividendsOnInvestmentSecurities
239000
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
55843000
CY2022Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
43303000
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
8599000
CY2022Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
4154000
CY2023Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
2853000
CY2022Q1 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
3221000
CY2023Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
788000
CY2022Q1 us-gaap Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
0
CY2023Q1 us-gaap Interest Expense
InterestExpense
12240000
CY2022Q1 us-gaap Interest Expense
InterestExpense
7375000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
43603000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35928000
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
4038000
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
3240000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
39565000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
32688000
CY2023Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1855000
CY2022Q1 us-gaap Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
1876000
CY2023Q1 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
252000
CY2022Q1 mfin Writedown Of Loan Collateral In Process Of Foreclosure
WritedownOfLoanCollateralInProcessOfForeclosure
386000
CY2023Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-90000
CY2022Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-133000
CY2023Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
570000
CY2022Q1 us-gaap Noninterest Income Other
NoninterestIncomeOther
172000
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
2083000
CY2022Q1 us-gaap Noninterest Income
NoninterestIncome
1529000
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
8836000
CY2022Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
7568000
CY2023Q1 mfin Loan Servicing Fee
LoanServicingFee
2222000
CY2022Q1 mfin Loan Servicing Fee
LoanServicingFee
1953000
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
3992000
CY2023Q1 mfin Collection Costs
CollectionCosts
1538000
CY2022Q1 mfin Collection Costs
CollectionCosts
1343000
CY2023Q1 mfin Lease And Rental Expense1
LeaseAndRentalExpense1
623000
CY2022Q1 mfin Lease And Rental Expense1
LeaseAndRentalExpense1
645000
CY2023Q1 mfin Regulatory Fees
RegulatoryFees
682000
CY2022Q1 mfin Regulatory Fees
RegulatoryFees
451000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
360000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
360000
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
2425000
CY2022Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1721000
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
18393000
CY2022Q1 us-gaap Noninterest Expense
NoninterestExpense
18033000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23255000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16184000
CY2023Q1 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
6382000
CY2022Q1 mfin Income Tax Expense Benefit On Net Investment
IncomeTaxExpenseBenefitOnNetInvestment
4831000
CY2023Q1 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
16873000
CY2022Q1 mfin Net Investment Income Loss After Taxes
NetInvestmentIncomeLossAfterTaxes
11353000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15361000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9841000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22342911
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24770134
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22975457
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25083566
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
300000
CY2022Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
200000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
16873000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11353000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
506000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1717000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
17379000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9636000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1512000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1512000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15867000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8124000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
370524000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
16873000
CY2023Q1 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1036000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
292000
CY2023Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.08
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
450000
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
8407000
CY2023Q1 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
438000
CY2022Q1 us-gaap Proceeds From Sale And Collection Of Receivables
ProceedsFromSaleAndCollectionOfReceivables
3856000
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
1863000
CY2023Q1 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
506000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
375153000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
355828000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11353000
CY2022Q1 mfin Distribution To Noncontrolling Interest
DistributionToNoncontrollingInterest
-1512000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
598000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
152000
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
617000
CY2022Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.08
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
2044000
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1717000
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
362041000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
16873000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11353000
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
4038000
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
3240000
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
264000
CY2022Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
172000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1300000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1640000
CY2023Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-2173000
CY2022Q1 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-2119000
CY2023Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
6437000
CY2022Q1 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
4170000
CY2023Q1 mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-2330000
CY2022Q1 mfin Net Change In Loan Collateral In Process Of Foreclosure
NetChangeInLoanCollateralInProcessOfForeclosure
-1396000
CY2023Q1 mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
-90000
CY2022Q1 mfin Gain Loss On Sale Of Loans And Investments
GainLossOnSaleOfLoansAndInvestments
-241000
CY2023Q1 mfin Net Change In Unrealized Depreciation On Investments Operating Activities
NetChangeInUnrealizedDepreciationOnInvestmentsOperatingActivities
-28000
CY2022Q1 mfin Net Change In Unrealized Depreciation On Investments Operating Activities
NetChangeInUnrealizedDepreciationOnInvestmentsOperatingActivities
0
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1036000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
598000
CY2023Q1 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-378000
CY2022Q1 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-18000
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8605000
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2455000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4120000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2833000
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-751000
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-327000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29127000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24654000
CY2023Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
230846000
CY2022Q1 us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
217495000
CY2023Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
143891000
CY2023Q1 mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
5526000
CY2022Q1 mfin Proceeds From Sale And Principal Payments Of Loan Collateral In Process Of Foreclosure
ProceedsFromSaleAndPrincipalPaymentsOfLoanCollateralInProcessOfForeclosure
5240000
CY2022Q1 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
129121000
CY2022Q1 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.02
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-81441000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-87685000
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
240056000
CY2022Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
200528000
CY2023Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
157100000
CY2022Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
119226000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1870000
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1984000
CY2023Q1 mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
1512000
CY2022Q1 mfin Distributions To Noncontrolling Interests
DistributionsToNoncontrollingInterests
1512000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
768000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
617000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
292000
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
152000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
79098000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77341000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26784000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14310000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
105598000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
124484000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
132382000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
138794000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
12372000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
7056000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
143000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12000
CY2023Q1 mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
6504000
CY2022Q1 mfin Non Cash Investing Loans Transferred To Loan Collateral In Process Of Foreclosure
NonCashInvestingLoansTransferredToLoanCollateralInProcessOfForeclosure
3040000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S., or GAAP, requires management to make estimates that affect the amounts reported in the consolidated financial statements and the accompanying notes. Accounting estimates and assumptions are those that management considers to be the most critical to an understanding of the consolidated financial statements because they inherently involve significant judgments and uncertainties. All of these estimates reflect management’s best judgment about current economic and market conditions and their effects based on information available as of the date of these consolidated financial statements. If such conditions change, it is reasonably possible that the judgments and estimates could change, which may result in future impairments of loans and loan collateral in process of foreclosure, goodwill and intangible assets, and investments, among other effects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5200000
CY2023Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P12M
CY2023Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
1300000
CY2023Q1 mfin Non Marketable Securities
NonMarketableSecurities
10700000
CY2022Q4 mfin Non Marketable Securities
NonMarketableSecurities
10300000
CY2023Q1 mfin Impact Of Equity Investment
ImpactOfEquityInvestment
2500000
CY2023Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
28000
CY2022Q1 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-91000
CY2023Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
CY2022Q1 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
0
CY2023Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
28000
CY2022Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-91000
CY2023Q1 us-gaap Employee Stock Ownership Plan Esop Weighted Average Purchase Price Of Shares Purchased
EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased
0.05
CY2023Q1 mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
36300000
CY2022 mfin Deferred Loan Origination Costs
DeferredLoanOriginationCosts
34900000
CY2023Q1 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
-1900000
CY2022Q1 mfin Amortization Of Loan Origination Fees Net
AmortizationOfLoanOriginationFeesNet
-2100000
CY2023Q1 mfin Loans Charged Off
LoansChargedOff
2500
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
79500
CY2023Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
19000000.0
CY2022Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
19500000
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
63845000
CY2023Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P20Y
CY2023Q1 us-gaap Goodwill
Goodwill
150800000
CY2022Q4 us-gaap Goodwill
Goodwill
150800000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21700000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22000000.0
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
400000
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21675000
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
22035000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
600000
CY2023Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
800000
CY2022Q1 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
600000
CY2023Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
6700000
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7000000.0
CY2023Q1 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
15361000
CY2022Q1 mfin Net Increase Decrease In Net Assets Resulting From Operations
NetIncreaseDecreaseInNetAssetsResultingFromOperations
9841000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
22342911
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24770134
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
149117
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
89507
CY2023Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
483429
CY2022Q1 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
223925
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
22975457
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25083566
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.69
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.40
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.67
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
466867
CY2023Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
1000000.0
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
53635000
CY2023Q1 mfin Tier One Leverage Capital Required For Capital Adequacy To Total Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToTotalAssets
0.15
CY2023Q1 mfin Tier One Leverage Capital Ratio
TierOneLeverageCapitalRatio
0.164
CY2023Q1 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
254883000
CY2022Q4 us-gaap Common Equity Tier One Capital
CommonEquityTierOneCapital
242049000
CY2023Q1 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
323671000
CY2022Q4 us-gaap Tier One Risk Based Capital
TierOneRiskBasedCapital
310837000
CY2023Q1 us-gaap Capital
Capital
348536000
CY2022Q4 us-gaap Capital
Capital
334913000
CY2023Q1 mfin Average Assets
AverageAssets
1969659000
CY2022 mfin Average Assets
AverageAssets
1917904000
CY2023Q1 us-gaap Risk Weighted Assets
RiskWeightedAssets
1948398000
CY2022Q4 us-gaap Risk Weighted Assets
RiskWeightedAssets
1888530000
CY2023Q1 us-gaap Tier One Leverage Capital Required For Capital Adequacy To Average Assets
TierOneLeverageCapitalRequiredForCapitalAdequacyToAverageAssets
0.040
CY2023Q1 us-gaap Tier One Leverage Capital Required To Be Well Capitalized To Average Assets
TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets
0.050
CY2023Q1 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.164
CY2022Q4 us-gaap Tier One Leverage Capital To Average Assets
TierOneLeverageCapitalToAverageAssets
0.162
CY2023Q1 mfin Common Equity Tier One Risk Based Capital Required For Capital Adequacy To Risk Weighted Assets
CommonEquityTierOneRiskBasedCapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.070
CY2023Q1 mfin Common Equity Tier One Capital Required To Be Well Capitalized To Risk Weighted Assets
CommonEquityTierOneCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.065
CY2023Q1 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.131
CY2022Q4 us-gaap Common Equity Tier One Capital Ratio
CommonEquityTierOneCapitalRatio
0.128
CY2023Q1 mfin Tier One Risk Based Capital Required For Capital Adequacy With Buffer To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredForCapitalAdequacyWithBufferToRiskWeightedAssets
0.085
CY2023Q1 us-gaap Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets
TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.080
CY2023Q1 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.166
CY2022Q4 us-gaap Tier One Risk Based Capital To Risk Weighted Assets
TierOneRiskBasedCapitalToRiskWeightedAssets
0.165
CY2023Q1 us-gaap Capital Required For Capital Adequacy To Risk Weighted Assets
CapitalRequiredForCapitalAdequacyToRiskWeightedAssets
0.105
CY2023Q1 us-gaap Capital Required To Be Well Capitalized To Risk Weighted Assets
CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets
0.100
CY2023Q1 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.179
CY2022Q4 us-gaap Capital To Risk Weighted Assets
CapitalToRiskWeightedAssets
0.177
CY2023Q1 mfin Effects Of The Transition Amount In Capital
EffectsOfTheTransitionAmountInCapital
6200000
CY2023Q1 mfin Tier One Capital Conversation Buffer
TierOneCapitalConversationBuffer
0.025
CY2022 mfin Tier One Capital Conversation Buffer
TierOneCapitalConversationBuffer
0.025
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Reclassifications</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Certain reclassifications have been made to prior year balances to conform with the current year presentation. These reclassifications have no effect on the previously reported results of operations.</span></p>
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
47000
CY2023Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
6782000
CY2023Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5153000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48529000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
54301000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
13000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
5822000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48492000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
44000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
44000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
9554000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
9209000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
9186000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
8193000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
34851000
CY2023Q1 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
31083000
CY2023Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
53635000
CY2023Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
48529000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
160000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
4961000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
4993000
CY2023Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
41368000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
1017000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
16949000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
4805000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
29525000
CY2023Q1 mfin Number Of Securities
NumberOfSecurities
56
CY2022Q4 mfin Number Of Securities
NumberOfSecurities
57
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
63845000
CY2021Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50166000
CY2023Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
18097000
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Write Offs
AllowanceForLoanAndLeaseLossesWriteOffs
7786000
CY2022Q4 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.017
CY2022Q1 us-gaap Allowance For Loan And Lease Loss Recovery Of Bad Debts
AllowanceForLoanAndLeaseLossRecoveryOfBadDebts
5066000
CY2023Q1 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
11315000
CY2022Q1 us-gaap Allowance For Loan And Lease Losses Writeoffs Net
AllowanceForLoanAndLeaseLossesWriteoffsNet
2720000
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
4038000
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
3240000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
70280000
CY2022Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
50686000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
0
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
4512000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
3698000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
1814000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Five Originated Four Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFiveOriginatedFourYearsBeforeCurrentFiscalYear
1685000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
6388000
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
18097000
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
70280000
CY2023Q1 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2023Q1 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0354
CY2023Q1 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
3.9057
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
63845000
CY2022Q4 mfin Percentage Of Allowance For Loan Losses
PercentageOfAllowanceForLoanLosses
1
CY2022Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoans
0.0333
CY2022Q4 mfin Allowance For Loan And Lease Losses Loans Acquired Percentage Of Loans Nonaccrual
AllowanceForLoanAndLeaseLossesLoansAcquiredPercentageOfLoansNonaccrual
1.9869
CY2023Q1 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
17994000
CY2022Q4 us-gaap Loans And Leases Receivable Impaired Nonperforming Nonaccrual Of Interest
LoansAndLeasesReceivableImpairedNonperformingNonaccrualOfInterest
32133000
CY2023Q1 mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
355000
CY2022 mfin Interest Income Foregone On Non Accrual Loans
InterestIncomeForegoneOnNonAccrualLoans
1267000
CY2023Q1 mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
78000
CY2022 mfin Amount Of Foregone Interest Applied To Principal
AmountOfForegoneInterestAppliedToPrincipal
375000
CY2023Q1 mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
2472000
CY2022 mfin Interest Foregone Life To Date
InterestForegoneLifeToDate
2419000
CY2023Q1 mfin Amount Of Foregone Interest Applied To Principal Life To Date
AmountOfForegoneInterestAppliedToPrincipalLifeToDate
813000
CY2022 mfin Amount Of Foregone Interest Applied To Principal Life To Date
AmountOfForegoneInterestAppliedToPrincipalLifeToDate
1204000
CY2023Q1 us-gaap Loans And Leases Receivable Ratio Of Nonperforming Loans To All Loans
LoansAndLeasesReceivableRatioOfNonperformingLoansToAllLoans
0.009
CY2023Q1 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
3.548
CY2022Q1 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-2368000
CY2022Q4 mfin Loans And Leases Receivable Allowances For Loan To Nonaccrual Loans
LoansAndLeasesReceivableAllowancesForLoanToNonaccrualLoans
1.987
CY2023Q1 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
1984180000
CY2023Q1 mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.0091
CY2022Q4 us-gaap Loans And Leases Receivable Loans In Process
LoansAndLeasesReceivableLoansInProcess
1916953000
CY2022 mfin Loans And Leases Receivable Non Performing Percentage
LoansAndLeasesReceivableNonPerformingPercentage
0.0170
CY2023Q1 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
17994000
CY2023Q1 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
18807000
CY2023Q1 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
3889000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceRecordedInvestment
32550000
CY2022Q4 us-gaap Impaired Financing Receivable With Related Allowance Unpaid Principal Balance
ImpairedFinancingReceivableWithRelatedAllowanceUnpaidPrincipalBalance
33754000
CY2022Q4 mfin Impaired Financing Receivables With Related Allowance Related Allowance
ImpairedFinancingReceivablesWithRelatedAllowanceRelatedAllowance
10806000
CY2023Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
16842000
CY2023Q1 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
14000
CY2022Q1 us-gaap Impaired Financing Receivable With Related Allowance Average Recorded Investment
ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
37816000
CY2022Q1 mfin Impaired Financing Receivable With Related Allowance Interest Income And Adjusted Interest Expense Accrual Method
ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAndAdjustedInterestExpenseAccrualMethod
130000
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
43555000
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1949631000
CY2023Q1 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2023Q1 mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
36300000
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
57618000
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
1882585000
CY2022Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
0
CY2022 mfin Capitalized Loan Origination Costs
CapitalizedLoanOriginationCosts
34900000
CY2023Q1 mfin Loan To Value Ratio
LoanToValueRatio
2
CY2022Q4 mfin Loan To Value Ratio
LoanToValueRatio
3.39
CY2022Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
21819000
CY2023Q1 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
6504000
CY2023Q1 mfin Loan In Process Of Foreclosure Loan Sales
LoanInProcessOfForeclosureLoanSales
-2210000
CY2023Q1 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-3317000
CY2023Q1 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-2329000
CY2023Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
20467000
CY2021Q4 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
37430000
CY2022Q1 mfin Loan In Process Of Foreclosure Loans Transfer
LoanInProcessOfForeclosureLoansTransfer
3040000
CY2022Q1 mfin Loan In Process Of Foreclosure Loans Cash Payment Received
LoanInProcessOfForeclosureLoansCashPaymentReceived
-2872000
CY2022Q1 mfin Loan In Process Of Foreclosure Loans Collateral Valuation Adjustments
LoanInProcessOfForeclosureLoansCollateralValuationAdjustments
-1396000
CY2022Q1 us-gaap Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
33834000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
603185000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
512008000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
412416000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
164401000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
163630000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
58750000
CY2023Q1 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
1914390000
CY2022Q4 mfin Debt Long Term And Short Term Funds Borrowed Amount
DebtLongTermAndShortTermFundsBorrowedAmount
1832184000
CY2023Q1 us-gaap Debt Weighted Average Interest Rate
DebtWeightedAverageInterestRate
0.0279
CY2023Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
6700000
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
7000000.0
CY2023Q1 mfin Reserve Deposits
ReserveDeposits
2000000.0
CY2022Q4 mfin Reserve Deposits
ReserveDeposits
1300000
CY2023Q1 mfin Listing Services Deposits From Other Financial Institutions
ListingServicesDepositsFromOtherFinancialInstitutions
10600000
CY2022Q4 mfin Listing Services Deposits From Other Financial Institutions
ListingServicesDepositsFromOtherFinancialInstitutions
12400000
CY2023Q1 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Or Less
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsOrLess
147179000
CY2023Q1 us-gaap Contractual Maturities Time Deposits100000 Or More Three Months Through Six Months
ContractualMaturitiesTimeDeposits100000OrMoreThreeMonthsThroughSixMonths
138645000
CY2023Q1 us-gaap Contractual Maturities Time Deposits100000 Or More Six Months Through12 Months
ContractualMaturitiesTimeDeposits100000OrMoreSixMonthsThrough12Months
278861000
CY2023Q1 us-gaap Contractual Maturities Time Deposits100000 Or More After12 Months
ContractualMaturitiesTimeDeposits100000OrMoreAfter12Months
1132380000
CY2023Q1 us-gaap Time Deposits100000 Or More
TimeDeposits100000OrMore
1697065000
CY2019Q3 us-gaap Notes Payable
NotesPayable
6000000.0
CY2020Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
25000000.0
CY2020Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-09-24
CY2007Q4 us-gaap Payments For Repurchase Of Trust Preferred Securities
PaymentsForRepurchaseOfTrustPreferredSecurities
2000000.0
CY2023Q1 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
43306000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10382000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
597000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
590000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
623000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
645000
CY2023Q1 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-56000
CY2022Q1 mfin Increase Decrease In Right Of Use Asset Obtained In Exchange For Operating Lease Liability
IncreaseDecreaseInRightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
-45000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9511000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9723000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2214000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2239000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8168000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8408000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
10382000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
10647000
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y3M18D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0566
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0566
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1876000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2508000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2492000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2440000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1213000
CY2023Q1 mfin Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
1290000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11819000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1437000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
43397000
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
11445000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses
9945000
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3730000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3730000
CY2023Q1 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
3041000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
3819000
CY2023Q1 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
1180000
CY2022Q4 mfin Deferred Tax Liabilities Unrealized Loss On Other Investments
DeferredTaxLiabilitiesUnrealizedLossOnOtherInvestments
1445000
CY2023Q1 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
23910000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
24458000
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2295000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2295000
CY2023Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
26205000
CY2022Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
26753000
CY2023Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2583000
CY2022Q1 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
504000
CY2023Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
789000
CY2022Q1 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
322000
CY2023Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
2246000
CY2022Q1 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
3220000
CY2023Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
764000
CY2022Q1 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
785000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6382000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4831000
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
44583
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
4884000
CY2022Q1 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3399000
CY2023Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
955000
CY2022Q1 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
665000
CY2023Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-1058000
CY2022Q1 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-713000
CY2023Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
515000
CY2022Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-54000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6382000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4831000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
992072
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
729812
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1111687
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2021Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
12.55
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.41
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
26093
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.08
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
23745
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.51
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1061849
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
9.38
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.51
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q1 mfin Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
25194
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
6.97
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.55
CY2023Q1 mfin Non Interest Expense Income
NonInterestExpenseIncome
16310000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23255000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
992072
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeUpperRangeLimit
9.38
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.53
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
548426
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeLowerRangeLimit
2.14
CY2022Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit
9.38
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.51
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
729812
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePriceRangeLowerRangeLimit
2.14
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Exercise Price Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableExercisePriceRangeUpperRangeLimit
9.38
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.50
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1200000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
900000
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y7M6D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
513423
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2022Q4 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.52
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
2951
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareLowerRangeLimit
4.89
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Forfeited Exercise Price Per Share Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsForfeitedExercisePricePerShareUpperRangeLimit
7.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
5.53
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
248212
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeLowerRangeLimit
4.89
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures In Period Grant Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresInPeriodGrantPricePerShareRangeUpperRangeLimit
7.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
6.55
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
262260
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Lower Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeLowerRangeLimit
4.89
CY2023Q1 mfin Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Options Exercise Price Per Share Range Upper Range Limit
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedOptionsExercisePricePerShareRangeUpperRangeLimit
7.25
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
6.49
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
400000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
5
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2023Q1 mfin Number Of Non Operating Segments
NumberOfNonOperatingSegments
1
CY2023Q1 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
55843000
CY2023Q1 mfin Interest Expense Net
InterestExpenseNet
12240000
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
43603000
CY2023Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
4038000
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
39565000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6382000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
16873000
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
15361000
CY2023Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1984180000
CY2023Q1 us-gaap Assets
Assets
2351670000
CY2023Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1913889000
CY2023Q1 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0299
CY2023Q1 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.1850
CY2023Q1 mfin Percentage Of Return On Average Stockholders Equity
PercentageOfReturnOnAverageStockholdersEquity
0.2072
CY2023Q1 mfin Interest Yield
InterestYield
0.1078
CY2023Q1 mfin Net Interest Margin Gross Percentage1
NetInterestMarginGrossPercentage1
0.0842
CY2023Q1 mfin Net Interest Margin Net Of Allowance Percentage
NetInterestMarginNetOfAllowancePercentage
0.0871
CY2023Q1 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0354
CY2023Q1 mfin Delinquency Status
DelinquencyStatus
0.0024
CY2023Q1 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
0.0235
CY2022Q1 mfin Interest Income Expense Operating
InterestIncomeExpenseOperating
43303000
CY2022Q1 mfin Interest Expense Net
InterestExpenseNet
7375000
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
35928000
CY2022Q1 us-gaap Provision For Other Credit Losses
ProvisionForOtherCreditLosses
3240000
CY2022Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
32688000
CY2022Q1 mfin Non Interest Expense Income
NonInterestExpenseIncome
16504000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16184000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4831000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
11353000
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1512000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
9841000
CY2022Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
1569441000
CY2022Q1 us-gaap Assets
Assets
1966625000
CY2022Q1 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1559304000
CY2022Q1 mfin Return On Average Assets Percentage
ReturnOnAverageAssetsPercentage
0.0241
CY2022Q1 mfin Percentage Of Return On Average Equity
PercentageOfReturnOnAverageEquity
0.1277
CY2022Q1 mfin Percentage Of Return On Average Stockholders Equity
PercentageOfReturnOnAverageStockholdersEquity
0.1370
CY2022Q1 mfin Interest Yield
InterestYield
0.1074
CY2022Q1 mfin Net Interest Margin Gross Percentage1
NetInterestMarginGrossPercentage1
0.0891
CY2022Q1 mfin Net Interest Margin Net Of Allowance Percentage
NetInterestMarginNetOfAllowancePercentage
0.0920
CY2022Q1 mfin Reserve Coverage Ratio
ReserveCoverageRatio
0.0323
CY2022Q1 mfin Delinquency Status
DelinquencyStatus
0.0027
CY2022Q1 mfin Chargeoffs To Loans Percentage
ChargeoffsToLoansPercentage
-0.0072
CY2023Q1 mfin Employment Agreement Description
EmploymentAgreementDescription
mployment agreements expire at various dates through 2027
CY2023Q1 mfin Employment Agreements Future Minimum Payments Due
EmploymentAgreementsFutureMinimumPaymentsDue
12000000.0
CY2023Q1 us-gaap Other Commitment
OtherCommitment
0
CY2023Q1 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
500000
CY2022 mfin Net Change In Unrealized Gains Losses Net Of Tax
NetChangeInUnrealizedGainsLossesNetOfTax
-4400000

Files In Submission

Name View Source Status
0000950170-23-018931-index-headers.html Edgar Link pending
0000950170-23-018931-index.html Edgar Link pending
0000950170-23-018931.txt Edgar Link pending
0000950170-23-018931-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mfin-20230331.htm Edgar Link pending
mfin-20230331.xsd Edgar Link pending
mfin-ex10_1.htm Edgar Link pending
mfin-ex31_1.htm Edgar Link pending
mfin-ex31_2.htm Edgar Link pending
mfin-ex32_1.htm Edgar Link pending
mfin-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mfin-20230331_cal.xml Edgar Link unprocessable
mfin-20230331_def.xml Edgar Link unprocessable
mfin-20230331_pre.xml Edgar Link unprocessable
mfin-20230331_lab.xml Edgar Link unprocessable
mfin-20230331_htm.xml Edgar Link completed
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending